TY - JOUR
T1 - Na+-H+ exchange inhibition attenuates ischemic injury in rat random pattern skin flap
T2 - The role of mitochondrial ATP-sensitive potassium channels
AU - Emami, Hamed
AU - Talab, Saman Shafaat
AU - Nezami, Behtash Ghazi
AU - Elmi, Azadeh
AU - Assa, Solmaz
AU - Ostovaneh, Mohammad Reza
AU - Dehpour, Ahmad Reza
PY - 2013/1/5
Y1 - 2013/1/5
N2 - Necrosis of distal portion of skin flaps due to ischemia still remains a problem in plastic surgery. Following ischemia, a cascade of deleterious events including over-activity of Na+-H+ Exchanger (NHE) takes place. In present study we evaluated the effect of the potent NHE inhibitor, 5-(N-ethyl-N-isopropyl) amiloride (EIPA) on ischemic tissue injury in a skin flap model, and investigated the role of mitochondrial ATP-sensitive K + channels (KATP) in this phenomenon. Seventy-eight rats were randomly divided into thirteen treatment groups (6 rats each). Four groups received different doses of EIPA in the flap. EIPA/GLY group received an effective dose of a KATP channel blocker, glibenclamide (GLY, 0.3 mg/kg) intraperitoneally (i.p.) 30 min before raising the flap, and a local effective dose of EIPA (0.1 mM) immediately after raising the flap. EIPA/diazoxide group (EIPA/DIA) received a sub-effective dose of diazoxide (7.5 mg/kg i.p.) 30 min before raising the flap and a local sub-effective dose of EIPA (0.075 mM). EIPA 0.1 and 0.2 mM significantly increased flap survival area compared to control group (56.01±6.1%, P<0.001). The protective effect of EIPA (0.1 mM) was abolished by administration of glibenclamide (0.3 mg/kg i.p.). Co-administration of a sub-effective dose of EIPA (0.075 mM), with a sub-effective dose of diazoxide (7.5 mg/kg i.p.) significantly improved flap survival (P<0.05). We demonstrated that the NHE inhibitor, EIPA can increase random pattern skin flap survival. Administration of diazoxide potentiates this effect, while glibenclamide abolishes that, implicating that the protective effect of EIPA is mediated through mitochondrial-KATP channels.
AB - Necrosis of distal portion of skin flaps due to ischemia still remains a problem in plastic surgery. Following ischemia, a cascade of deleterious events including over-activity of Na+-H+ Exchanger (NHE) takes place. In present study we evaluated the effect of the potent NHE inhibitor, 5-(N-ethyl-N-isopropyl) amiloride (EIPA) on ischemic tissue injury in a skin flap model, and investigated the role of mitochondrial ATP-sensitive K + channels (KATP) in this phenomenon. Seventy-eight rats were randomly divided into thirteen treatment groups (6 rats each). Four groups received different doses of EIPA in the flap. EIPA/GLY group received an effective dose of a KATP channel blocker, glibenclamide (GLY, 0.3 mg/kg) intraperitoneally (i.p.) 30 min before raising the flap, and a local effective dose of EIPA (0.1 mM) immediately after raising the flap. EIPA/diazoxide group (EIPA/DIA) received a sub-effective dose of diazoxide (7.5 mg/kg i.p.) 30 min before raising the flap and a local sub-effective dose of EIPA (0.075 mM). EIPA 0.1 and 0.2 mM significantly increased flap survival area compared to control group (56.01±6.1%, P<0.001). The protective effect of EIPA (0.1 mM) was abolished by administration of glibenclamide (0.3 mg/kg i.p.). Co-administration of a sub-effective dose of EIPA (0.075 mM), with a sub-effective dose of diazoxide (7.5 mg/kg i.p.) significantly improved flap survival (P<0.05). We demonstrated that the NHE inhibitor, EIPA can increase random pattern skin flap survival. Administration of diazoxide potentiates this effect, while glibenclamide abolishes that, implicating that the protective effect of EIPA is mediated through mitochondrial-KATP channels.
KW - Amiloride
KW - Ischemia injury
KW - Skin flap
UR - http://www.scopus.com/inward/record.url?scp=84871921035&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84871921035&partnerID=8YFLogxK
U2 - 10.1016/j.ejphar.2012.10.022
DO - 10.1016/j.ejphar.2012.10.022
M3 - Article
C2 - 23123348
AN - SCOPUS:84871921035
SN - 0014-2999
VL - 698
SP - 330
EP - 334
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 1-3
ER -